# PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate

> **NCT03222128** · NA · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 1074 (actual)

## Conditions studied

- Symptomatic Severe Aortic Stenosis

## Interventions

- **DEVICE:** TAVR

## Key facts

- **NCT ID:** NCT03222128
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-17
- **Primary completion:** 2015-11-18
- **Final completion:** 2024-10-09
- **Target enrollment:** 1074 (ACTUAL)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03222128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03222128, "PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03222128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*